 Antineoplastic Agents, Phytogenic
"Antineoplastic Agents, Phytogenic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity.
| Descriptor ID |
D000972
|
| MeSH Number(s) |
D27.505.954.248.179
|
| Concept/Terms |
Antineoplastic Agents, Phytogenic- Antineoplastic Agents, Phytogenic
- Agents, Phytogenic Antineoplastic
- Phytogenic Antineoplastic Agents
- Antineoplastics, Phytogenic
- Phytogenic Antineoplastics
- Antineoplastics, Botanical
- Botanical Antineoplastics
|
Below are MeSH descriptors whose meaning is more general than "Antineoplastic Agents, Phytogenic".
Below are MeSH descriptors whose meaning is more specific than "Antineoplastic Agents, Phytogenic".
This graph shows the total number of publications written about "Antineoplastic Agents, Phytogenic" by people in this website by year, and whether "Antineoplastic Agents, Phytogenic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 | | 1995 | 1 | 0 | 1 | | 1996 | 7 | 5 | 12 | | 1997 | 2 | 2 | 4 | | 1998 | 8 | 2 | 10 | | 1999 | 1 | 0 | 1 | | 2000 | 8 | 0 | 8 | | 2001 | 1 | 4 | 5 | | 2002 | 8 | 2 | 10 | | 2003 | 4 | 2 | 6 | | 2004 | 4 | 4 | 8 | | 2005 | 6 | 1 | 7 | | 2006 | 16 | 1 | 17 | | 2007 | 8 | 0 | 8 | | 2008 | 4 | 3 | 7 | | 2009 | 10 | 6 | 16 | | 2010 | 9 | 2 | 11 | | 2011 | 3 | 0 | 3 | | 2012 | 6 | 2 | 8 | | 2013 | 6 | 3 | 9 | | 2014 | 5 | 1 | 6 | | 2015 | 5 | 1 | 6 | | 2016 | 3 | 0 | 3 | | 2018 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Antineoplastic Agents, Phytogenic" by people in Profiles.
-
Singhal J, Chikara S, Horne D, Salgia R, Awasthi S, Singhal SS. 2'-Hydroxyflavanone inhibits in vitro and in vivo growth of breast cancer cells by targeting RLIP76. Mol Carcinog. 2018 12; 57(12):1751-1762.
-
Sun ZL, Zhang YZ, Zhang F, Zhang JW, Zheng GC, Tan L, Wang CZ, Zhou LD, Zhang QH, Yuan CS. Quality assessment of Penthorum chinense Pursh through multicomponent qualification and fingerprint, chemometric, and antihepatocarcinoma analyses. Food Funct. 2018 Jul 17; 9(7):3807-3814.
-
Ugolkov A, Gaisina I, Zhang JS, Billadeau DD, White K, Kozikowski A, Jain S, Cristofanilli M, Giles F, O'Halloran T, Cryns VL, Mazar AP. GSK-3 inhibition overcomes chemoresistance in human breast cancer. Cancer Lett. 2016 10 01; 380(2):384-92.
-
Rosenberg J, Fisher WG, Guerrero M, Smart S, Levisay J, Feldman T, Salinger M. Drug-Coated Balloon Venoplasty for In-Stent Restenosis in a Patient With Recurrent Pulmonary Vein Stenosis Post Ablation for Atrial Fibrillation: Initial Experience With a New Treatment Technique. J Invasive Cardiol. 2016 May; 28(5):E44-8.
-
Wang CZ, Anderson S, DU W, He TC, Yuan CS. Red ginseng and cancer treatment. Chin J Nat Med. 2016 Jan; 14(1):7-16.
-
Wang CZ, Anderson S, Yuan CS. Phytochemistry and Anticancer Potential of Notoginseng. Am J Chin Med. 2016; 44(1):23-34.
-
Wang CZ, Qi LW, Yuan CS. Cancer Chemoprevention Effects of Ginger and its Active Constituents: Potential for New Drug Discovery. Am J Chin Med. 2015; 43(7):1351-63.
-
Komatsu M, Wheeler HE, Chung S, Low SK, Wing C, Delaney SM, Gorsic LK, Takahashi A, Kubo M, Kroetz DL, Zhang W, Nakamura Y, Dolan ME. Pharmacoethnicity in Paclitaxel-Induced Sensory Peripheral Neuropathy. Clin Cancer Res. 2015 Oct 01; 21(19):4337-46.
-
Gao SY, Gong YF, Sun QJ, Bai J, Wang L, Fan ZQ, Sun Y, Su YJ, Gang J, Ji YB. Screening antitumor bioactive fraction from Sauromatum giganteum (Engl.) Cusimano & Hett and sensitive cell lines with the serum pharmacology method and identification by UPLC-TOF-MS. Molecules. 2015 Mar 06; 20(3):4290-306.
-
Groo AC, Bossiere M, Trichard L, Legras P, Benoit JP, Lagarce F. In vivo evaluation of paclitaxel-loaded lipid nanocapsules after intravenous and oral administration on resistant tumor. Nanomedicine (Lond). 2015 Mar; 10(4):589-601.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|